Ditchcarbon
  • Contact
  1. Organizations
  2. Eurand, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 2 days ago

Eurand, Inc. Sustainability Profile

Company website

Eurand, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 2000, the company has established itself as a leader in developing innovative drug delivery systems, particularly in the areas of oral and injectable formulations. With a focus on enhancing bioavailability and patient compliance, Eurand's core products include advanced formulations that utilise proprietary technologies, setting them apart in a competitive market. The company operates primarily in North America and Europe, catering to a diverse clientele that includes major pharmaceutical firms. Notable achievements include successful partnerships and collaborations that have expanded its market reach and product offerings. Eurand, Inc. continues to be recognised for its commitment to quality and innovation, solidifying its position as a trusted name in the pharmaceutical landscape.

DitchCarbon Score

How does Eurand, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Eurand, Inc.'s score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.

34%

Let us know if this data was useful to you

Eurand, Inc.'s reported carbon emissions

Eurand, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Eurand may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As such, the company appears to be operating without a defined strategy for addressing carbon emissions or contributing to climate action within its industry context.

How Carbon Intensive is Eurand, Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Eurand, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Eurand, Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Eurand, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Eurand, Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Eurand, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Eurand, Inc.'s Emissions with Industry Peers

Biogen

US
•
Pharmaceutical Preparation Manufacturing
Updated about 4 hours ago

Assertio Holdings, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 3 hours ago

Lifecycle Pharma, Inc.

US
Updated about 1 month ago

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated less than a minute ago

Regeneron

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy